REFERENCES
Arjona, A., Barquero, N., Doménech, A., Tejerizo, G., Collado, V. M., Toural, C., . . . Gomez-Lucia, E. (2007). Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).Journal of Feline Medicine and Surgery, 9 (1), 14-22.
Bande, F., Arshad, S. S., Hassan, L., Zakaria, Z., Sapian, N. A., Rahman, N. A., & Alazawy, A. (2012). Prevalence and risk factors of feline leukaemia virus and feline immunodeficiency virus in peninsular Malaysia. BMC veterinary research, 8 (1), 33.
Barr, M. C., Pough, M. B., Jacobson, R. H., & Scott, F. W. (1991). Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection.Journal of the American Veterinary Medical Association, 199 (10), 1377-1381.
Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., . . . Tozzini, F. (1995). Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clinical microbiology reviews, 8 (1), 87-112.
Berger, A., Willi, B., Meli, M. L., Boretti, F. S., Hartnack, S., Dreyfus, A., . . . Hofmann-Lehmann, R. (2015). Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland. BMC veterinary research, 11 (1), 282.
Binns, S., Dawson, S., Speakman, A., Cuevas, L., Hart, C., Gaskell, C., . . . Gaskell, R. (2000). A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. Journal of Feline Medicine & Surgery, 2 (3), 123-133.
Blanco, K., Prendas, J., Corte, R., Jimenez, C., & Dolz, G. (2009). Seroprevalence of viral infections in domestic cats in Costa Rica. 71 (5), 661.
Chang, H. W., de Groot, R. J., Egberink, H. F., & Rottier, P. J. (2010). Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene . Journal of General Virology.
Chen, D. (2013). Diagnosis and Treatment of Feline Viral Rhinotracheitis in South China Tigers(Panthera tigris amoyensis). Chinese Journal of Wildlife .
Cong, W., Meng, Q.-F., Blaga, R., Villena, I., Zhu, X.-Q., & Qian, A.-D. (2016). Toxoplasma gondii, Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in northwest China: co-infections and risk factors. Parasitology research, 115 (1), 217-223.
Dall’Ara, P., Labriola, C., Sala, E., Spada, E., Magistrelli, S., & Lauzi, S. (2019). Prevalence of serum antibody titres against feline panleukopenia, herpesvirus and calicivirus infections in stray cats of Milan, Italy. Preventive veterinary medicine, 167 , 32-38.
Dorny, P., Speybroeck, N., Verstraete, S., Baeke, M., De Becker, A., Berkvens, D., & Vercruysse, J. (2002). Serological survey Toxoplasma gondii of a on feline immunodeficiency virus and feine leukaemia virus in urban stray cats in Belgium. Veterinary Record, 151 (21), 626-629.
Eckstrand, C. D., Sparger, E. E., & Murphy, B. G. (2017). Central and peripheral reservoirs of feline immunodeficiency virus in cats: a review. 98 (8), 1985-1996.
Filoni, C., Catão-Dias, J. L., Cattori, V., Willi, B., Meli, M. L., Corrêa, S. H. R., . . . Marvulo, M. F. V. (2012). Surveillance using serological and molecular methods for the detection of infectious agents in captive Brazilian neotropic and exotic felids. Journal of Veterinary Diagnostic Investigation, 24 (1), 166-173.
Gao, Y. W., Xia, X. Z., Rong_Liang, H. U., Huang, G., Chun_Zhong, X. U., & Wang, T. D. (2003). Characterization and hypervariable region analysis of two feline calicivirus isolates from cheetah and tiger. Chinese Journal of Preventive Veterinary Medicine .
Gates, M., Vigeant, S., & Dale, A. (2017). Prevalence and risk factors for cats testing positive for feline immunodeficiency virus and feline leukaemia virus infection in cats entering an animal shelter in New Zealand. New Zealand veterinary journal, 65 (6), 285-291.
Gleich, S. E., Krieger, S., & Hartmann, K. (2009). Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. Journal of Feline Medicine and Surgery, 11 (12), 985-992.
Levy, J. K., Scott, H. M., Lachtara, J. L., & Crawford, P. C. (2006). Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. Journal of the American Veterinary Medical Association, 228 (3), 371-376.
Li, C., Liu, Q., Kong, F., Guo, D., Zhai, J., Su, M., & Sun, D. (2019). Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP‐suspected cats in China. Transboundary and emerging diseases, 66 (2), 763-775.
Luckman, C., & Gates, M. C. (2017). Epidemiology and clinical outcomes of feline immunodeficiency virus and feline leukaemia virus in client-owned cats in New Zealand.Journal of Feline Medicine and Surgery Open Reports, 3 (2), 2055116917729311.
Lutz, H., Addie, D., Belák, S., Boucraut-Baralon, C., Egberink, H., Frymus, T., . . . Lloret, A. (2009). Feline leukaemia. ABCD guidelines on prevention and management.Journal of Feline Medicine & Surgery, 11 (7), 565-574.
Malik, R., Kendall, K., Cridland, J., Coulston, S., Stuart, A., Snow, D., & Love, D. (1997). Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Australian Veterinary Journal, 75 (5), 323-327.
Nakamura, Y., Nakamura, Y., Ura, A., Hirata, M., Sakuma, M., Sakata, Y., . . . Endo, Y. (2010). An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan. Journal of Veterinary Medical Science , 1003030181-1003030181.
Niu, J. T., Yi, S. S., Hu, G. X., Guo, Y. B., Zhang, S., Dong, H., . . . Wang, K. (2018). Prevalence and molecular characterization of parvovirus in domestic kittens from Northeast China during 2016-2017. Japanese Journal of Veterinary Research, 66 (3), 145-155.
Norris, J. M., Bell, E. T., Hales, L., Toribio, J.-A. L., White, J. D., Wigney, D. I., . . . Malik, R. (2007). Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia. Journal of Feline Medicine and Surgery, 9 (4), 300-308.
Pan, M.-q., Wang, J.-c., & Wang, Y.-j. (2018). The prevalence and genetic diversity of feline immunodeficiency virus and feline leukemia virus among stray cats in Harbin, China. Turkish Journal of Zoology, 42 (2), 245-251.
Pedersen, N. (1983). Feline infectious peritonitis and feline enteric coronavirus infections. 1. Feline enteric coronaviruses [Cats]. Feline Practice (USA) .
Phillips, T. R., Lamont, C., Konings, D. A. M., Shacklett, B. L., & Elder, J. H. (1992). Identification of the Rev transactivation and Rev–responsive elements of feline immunodeficiency virus. Journal of Virology, 66 (9), 5464-5471.
Qiu, W., Xia, X., Fan, Q., He, H., Huang, G., Yu, C., . . . Wang, C. (2000). Isolation and identification of tiger’s feline panleukopenia virus. Chinese Journal of Preventive Veterinary Medicine, 22 (4), 249-251.
Reese, M. J., Patterson, E. V., Tucker, S. J., Dubovi, E. J., Davis, R. D., Crawford, P. C., & Levy, J. K. (2008). Effects of anesthesia and surgery on serologic responses to vaccination in kittens. Journal of the American Veterinary Medical Association, 233 (1), 116-121.
Tekes, G., & Thiel, H.-J. (2016). Feline coronaviruses: pathogenesis of feline infectious peritonitis. InAdvances in virus research (Vol. 96, pp. 193-218): Elsevier.
Wang, J., Wei, L., Rui, F. U., Li, X. B., Wang, S. J., Gong, W., . . . Zheng-Ming, H. E. (2014). Establishment and Preliminary Application of ELISA for Detecting Antibody to Felid Herpesvirus 1 in Cat. Laboratory Animal Science .
Xu, C.-C., Shi-Ling, H. U., Chen, S. J., Liu, C. G., Liu, Y., & Yan-Li, L. (2017). Epidemiologicin vestigate of feline FHV and FCV infection in Beijing. Chinese Journal of Veterinary Medicine .
Yang, S., Xia, X., Qiao, J., Liu, Q., Chang, S., Xie, Z., . . . Gao, Y. (2008). Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV. Vaccine, 26 (11), 1482-1487.